ctdna allows for the prediction of outcomes following liso-cel infusion in patients with lbcl
Published 5 months ago • 55 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
5:56
detection of ctdna in patients with mcl and cll
-
1:28
the remaining hurdles for using ctdna in lymphoma
-
3:59
using enhanced ctdna profiling to identify molecular determinants of response in r/r mcl
-
1:37
the role of ctdna in hodgkin lymphoma
-
3:05
the clinical use of circulating tumor dna in t-cell lymphomas
-
1:47
using peripheral blood ctdna-sequencing for pcnsl risk profiling
-
1:38
using circulating tumor dna in lymphoma: clinical trials & clinical practice
-
36:38
how to make the most of stage iv decision making for patients and caregivers
-
58:52
ctdna and mrd | 2023 best of gi cancer conference
-
4:23
illumina oncology - clinical utility of ctdna testing
-
3:10
the potential for early identification of relapse in dlbcl using serial ctdna sampling
-
2:33
linking the diagnosis-to-treatment interval with ctdna
-
2:58
using ctdna assays to monitor clonal evolution in fl
-
1:15
biomarkers being explored in hodgkin lymphoma: the role of ctdna
-
0:42
ctdna in clinical practice for melanoma
-
35:05
a ctdna assay for remote monitoring and risk stratification of crc patients
-
1:51
a positive ctdna test after adjuvant therapy: 2023 best of gi
-
0:42
what future does ctdna have as a biomarker in breast cancer?
-
0:40
expanding the use of ctdna in clinical trials
-
0:51
tracking clonal evolution in colorectal cancer using ctdna
-
0:38
the functional role of cd4- and cd8-expressing t-cells in aml
-
46:53
ctdna and mrd: who, when, and then what? | 2022 evolution conference